Related Experiment Video
Updated: Jan 24, 2026
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
Ghanbar Mahmoodi Chalbatani1, Hassan Dana1,2, Elahe Gharagouzloo1
1Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran.
Abstract:
Cancer is one of the most complex diseases that has resulted in multiple genetic disorders and cellular abnormalities. Globally, cancer is the most common health concern disease that is affecting human beings. Great efforts have been made over the past decades in biology with the aim of searching novel and more efficient tools in therapy. Thus, small interfering RNAs (siRNAs) have been considered one of the most noteworthy developments which are able to regulate gene expression following a process known as RNA interference (RNAi). RNAi is a post-transcriptional mechanism that involves the inhibition of gene expression through promoting cleavage on a specific area of a target messenger RNA (mRNA). This technology has shown promising therapeutic results for a good number of diseases, especially in cancer. However, siRNA therapeutics have to face important drawbacks in therapy including stability and successful siRNA delivery in vivo. In this regard, the development of effective siRNA delivery systems has helped addressing these issues by opening novel therapeutic windows which have allowed to build up important advances in Nanomedicine. In this review, we discuss the progress of siRNA therapy as well as its medical application via nanoparticle-mediated delivery for cancer treatment.
Insights
Small interfering RNAs (siRNAs) offer promising cancer therapy by regulating gene expression via RNA interference (RNAi). Nanoparticle delivery systems enhance siRNA stability and in vivo efficacy for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Nanomedicine
Background:
- Cancer is a complex disease with genetic and cellular abnormalities, representing a major global health concern.
- Small interfering RNAs (siRNAs) utilize RNA interference (RNAi) to regulate gene expression post-transcriptionally by targeting specific messenger RNA (mRNA).
- While siRNA therapy shows promise for various diseases, particularly cancer, challenges remain regarding in vivo stability and effective delivery.
Purpose of the Study:
- To review the advancements in siRNA therapy for cancer treatment.
- To discuss the application of nanoparticle-mediated delivery systems for enhancing siRNA therapeutics.
- To highlight the progress and potential of nanomedicine in overcoming siRNA delivery challenges.
Main Methods:
- Review of current literature on siRNA technology and RNA interference (RNAi).
- Analysis of nanoparticle-mediated delivery systems for siRNA therapeutics.
- Exploration of medical applications and therapeutic outcomes in cancer treatment.
Main Results:
- siRNA technology provides a novel approach to gene expression regulation for therapeutic purposes.
- Nanoparticle delivery systems significantly improve siRNA stability and facilitate targeted in vivo delivery.
- These advancements open new therapeutic avenues, particularly in nanomedicine for cancer treatment.
Conclusions:
- siRNA therapy, enhanced by nanoparticle delivery, represents a significant advancement in cancer treatment.
- Nanomedicine plays a crucial role in addressing the limitations of siRNA therapeutics, improving their clinical applicability.
- Further development in this area holds substantial promise for effective cancer therapy.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
02:30Small interfering RNAs (siRNA)
02:57piRNA - Piwi-interacting RNAs
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:39lncRNA - Long Non-coding RNAs
02:39lncRNA - Long Non-coding RNAs